Dr. Marie-Eve Robinson is a pediatric endocrinologist at the Children’s Hospital of Eastern Ontario, as well as a clinician investigator and assistant professor at the University of Ottawa. She holds a University of Ottawa Clinical Research Chair in Genetic Skeletal Disorders. She is the scientific director of SkeleTal Research on Novel Genes Program (STRONG Program), which aims to better characterize the phenotype of rare genetic bone disorders and identify new candidate genes associated with such disorders. Additional studies focus on drug therapy in osteogenesis imperfecta. Dr. Robinson is involved in national and international efforts to advance knowledge on pediatric bone diseases. She is the co-chair of the Canadian Consortium on Children’s Bone Health (CCCBH), a national network of Canadian pediatric endocrinologists working with children with pediatric bone disorders.
She is the chair of a subcommittee of the Pediatric Endocrine Society (PES) Bone and Mineral Interest Group aiming at identifying knowledge gaps and advancing pediatric bone health knowledge among pediatric endocrinologists across North America. Finally, she is involved in outreach programs aimed at improving the care of children with osteogenesis imperfecta living in developing countries such as Ecuador and Haiti.
Related News
Research Projects
-
Impacting the physical activity confidence of children with medical conditions or disabilities: A randomized controlled trial
27/03/2025
Youth with medical conditions or disabilities (MCD) seldom achieve healthy physical activity recommendations. Barriers include a perceived lack of competence, fear of pain/symptom exacerbation, or physical function changes. A 12-week intervention targeting physical activity confidence was evaluated among youth with MCD. The study found that youth who were confident were more likely to engage in physical activity. The in-person intervention increased participants’ activity confidence. The limited impact of the virtual format suggests that implementing new skills with peers is critically important for enhancing activity confidence. Further research is required to evaluate whether confidence gains could be sustained beyond the study intervention, would longitudinally increase activity participation over time, or would transfer to other activity settings.
-
Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy
18/01/2024
This prospective study examined clinical and skeletal factors associated with new vertebral fractures over 12 months in glucocorticoid‑treated children and young adults with Duchenne muscular dystrophy. The findings showed that having one or more existing vertebral or non‑vertebral fractures—and greater bone age delay—were the strongest predictors of incident vertebral fractures. These results highlight the importance of preventing first fractures and suggest that markers of glucocorticoid exposure may help identify patients who should be prioritized for early fracture‑prevention strategies.
-
Teaching Adolescents With Type 1 Diabetes Self-Compassion (TADS) to Reduce Diabetes Distress: Protocol for a Randomized Controlled Trial
26/12/2023
This randomized controlled trial aims to evaluate whether a web‑based mindful self‑compassion program can reduce diabetes distress and related mental health challenges among adolescents living with type 1 diabetes. By comparing the intervention with standard care, the study will assess impacts on emotional well‑being, diabetes‑related behaviors, and glycemic control over 12 months. The findings are expected to inform scalable psychological supports that help adolescents better manage the emotional demands of living with type 1 diabetes.
-
Standardized growth charts for children with osteogenesis imperfecta
15/03/2023
Our standardized OI type- and sex-specific growth charts can be used to assess the growth of individuals with OI from infancy to adulthood.
-
From “ACAN” to “I CAN”: Restoring wellness in a boy with severe osteochondritis dissecans through diagnostic precision combined with optimal medical, surgical and rehabilitation management
13/03/2023
Osteochondritis dissecans (OCD) is a disease of the joints characterized by idiopathic focal subchondral lesions. Aggrecan, a proteoglycan encoded by the ACAN gene, is important for cartilage structure and function. We describe the clinical evolution of a patient with short stature, multi-focal OCD, and subchondral osteopenia that appeared linked to a novel pathogenic ACAN variant. A multi-disciplinary approach including medical (bisphosphonate) therapy, surgical intervention and rehabilitation were successful in restoring wellness and physical function.